Gabapentin Capsule
Product Images NDC 71205-930

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapentin 01)

FDA Label Image

Figure 1 (Gabapentin 02)

FDA Label Image

Figure 2 (Gabapentin 03)

Figure 2 (Gabapentin 03)
This appears to be a chart or table related to a medication study. The study involves a "Week Dose Duration Period" and a "Fixed Dose Period" with either a placebo or Gabapentin (at either 1800mg/day or 2400mg/day). There is also a "Mean Pain Score" recorded over time. However, without more context or information it is difficult to provide a more detailed description.*
FDA Label Image

Figure 3 (Gabapentin 04)

FDA Label Image

Figure 4 (Gabapentin 05)

FDA Label Image

71205-928-30 (Image 01)

71205-928-30 (Image 01)
This is a description of Gabapentin Capsules, a prescription medication used to treat seizures and nerve pain. It contains 30 capsules, each with 100mg of gabapentin. The capsules are white and off-white in color and are imprinted with "SG" on the cap and "179" on the body. The medication should be kept out of reach of children and stored at 68°-77°F. A medication guide should be provided to each patient when dispensing. The product is distributed by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY.*
FDA Label Image

71205-930-30 (Image 02)

71205-930-30 (Image 02)
This is a medication description for Gabapentin 400mg capsules manufactured by ScieGen Pharmaceuticals. The medication is available in a package containing 30 capsules. Patients receiving it should be given a medication guide. The capsules are filled with a white to off-white powder and are threaded in size 0 hard gelatin capsules of opaque orange color with imprints on the cap and body. The product ID for this medication is QG093030. The medication should be stored at room temperature (20°-25°C or 68°-77°F), away from children.*
FDA Label Image

71205-929-30 (Image 03)

71205-929-30 (Image 03)
This is a medication label for Gabapentin 300mg capsules manufactured by ScieGen Pharmaceuticals, Inc. and packaged by Proficient Rx LP. The capsules are white to off-white in color and come in a size 1 hard gelatin capsule with an opaque yellow cap and body. Each capsule contains 300mg of Gabapentin, USP. The label includes the product ID as QG092930 and indicates that a medication guide should be provided to each patient when dispensing Gabapentin Capsules. The medication should be stored between 20°C to 25°C (68°F to 77°F) and kept out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.